Changes in cholesterol-lowering medications use over a decade in community-dwelling older adults
- PMID: 23780807
- PMCID: PMC3707940
- DOI: 10.1345/aph.1S050
Changes in cholesterol-lowering medications use over a decade in community-dwelling older adults
Abstract
Background: The impact of evidence-based guidelines and controlled trial data on use of cholesterol-lowering medications in older adults is unclear.
Objective: To examine whether utilization patterns of cholesterol-lowering medications in community-dwelling older adults changed following the release of the National Cholesterol Education Program Adult Treatment Panel III guidelines and results from the Prospective Study of Pravastatin in the Elderly at Risk in 2002.
Methods: Community-dwelling elderly individuals who were enrolled in the Health, Aging and Body Composition Study in 1997-1998 were followed for up to 11 years. An interrupted time series analysis with multivariable generalized estimating equations (GEEs) was used to examine changes in level and trend in cholesterol-lowering medication use before and after 2002, adjusting for sociodemographics, health-related behaviors, and health status.
Results: Cholesterol-lowering medication use increased nearly 3-fold from 14.9% in 1997-1998 to 42.6% in 2007-2008, with statins representing the most common class used (87-94%). Multivariable GEE results revealed no significant difference in the level of cholesterol-lowering medication use after 2002 (adjusted OR 0.95; 95% CI 0.89-1.02). Multivariable GEE results revealed that trend changes in the rate of increase in cholesterol-lowering medication declined after 2002 (adjusted ratio of ORs 0.92; 95% CI 0.89-0.95).
Conclusions: The use of cholesterol-lowering medication increased substantially over a decade in community-dwelling elderly individuals but was not related to a change in level or trend following the release of the guidelines and evidence-based data.
Conflict of interest statement
Figures
References
-
- Schwartz JB, Zipes DP. Cardiovascular Disease in the Elderly. In: Bonow RO, Mann DL, Zipes DP, Libby P, editors. Bonow: Braunwald’s Heart Disease - A Textbook of Cardiovascular Medicine. 9. Philadelphia, PA: Saunders, An Imprint of Elsevier; 2011. pp. 1727–57.
-
- National Center for Health Statistics. Health, United States, 2010: With Special Features on Death and Dying. Hyattsville, MD: 2011. - PubMed
-
- Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356:2388–98. Epub 2007/06/08. 10.1056/NEJMsa053935. - PubMed
-
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med. 1988;148:36–69. Epub 1988/01/01. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AG034056/AG/NIA NIH HHS/United States
- N01-AG-6-2101/AG/NIA NIH HHS/United States
- R01-HS018721/HS/AHRQ HHS/United States
- R01-AG 027017/AG/NIA NIH HHS/United States
- R01 NR010135/NR/NINR NIH HHS/United States
- N01-AG-6-2103/AG/NIA NIH HHS/United States
- R01-NR012459/NR/NINR NIH HHS/United States
- R01 NR012459/NR/NINR NIH HHS/United States
- P30-AG024827/AG/NIA NIH HHS/United States
- K12 HS019461/HS/AHRQ HHS/United States
- N01-AG-6-2106/AG/NIA NIH HHS/United States
- T32 AG021885/AG/NIA NIH HHS/United States
- R01-NR010135/NR/NINR NIH HHS/United States
- R01-AG034056/AG/NIA NIH HHS/United States
- R01-HS017695/HS/AHRQ HHS/United States
- K07 AG033174/AG/NIA NIH HHS/United States
- P30 AG024827/AG/NIA NIH HHS/United States
- R01 AG027017/AG/NIA NIH HHS/United States
- K07-AG033174/AG/NIA NIH HHS/United States
- R01-AG028050/AG/NIA NIH HHS/United States
- T32-AG021885/AG/NIA NIH HHS/United States
- R01 HS018721/HS/AHRQ HHS/United States
- K12-HS019461/HS/AHRQ HHS/United States
- R01 HS017695/HS/AHRQ HHS/United States
- R01 AG028050/AG/NIA NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
